Study of Outcomes of Radiofrequency Ablation of Lung Tumors

StatusSuspended
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 2025 to Mar 2027
    • Study completion date: Feb 2026 to Mar 2028
    v22
  2. 2 versions Re-verified since Jan 4, 2025, no change to tracked fieldsv20-v21
  3. Primary completion date: Dec 2023 to Dec 2025
    • Study completion date: Dec 2023 to Feb 2026
    v19
  4. Primary and study completion dates: Dec 2022 to Dec 2023v18
  5. Primary completion date: Dec 2021 to Dec 2022v17
Show 15 earlier versionsHide 15 earlier versions
  1. Primary completion date: Dec 2020 to Dec 2021
    • Study completion date: Dec 2020 to Dec 2022
    v16
  2. 5 versions Re-verified since Apr 3, 2015, no change to tracked fieldsv11-v15
  3. Primary endpoint revisedv10
  4. Trial status: Recruiting to Suspended
    • Primary and study completion dates: Dec 2020
    • Site details revised
    v9
  5. Site contact updatedv8
  6. Secondary endpoints: details revised at 1 of 2 entriesv7
  7. Re-verified, no change to tracked fieldsv6
  8. Phase: Not applicable to Not specified
    • Primary endpoints: 2 to 1
    • Secondary endpoints revised (2)
    • Site contact updated
    v5
  9. Re-verified, no change to tracked fieldsv4
  10. Site contact updatedv3
  11. Primary endpoints: 3 to 2v2 Show 4 more changesShow less
    • Secondary endpoints revised (2)
    • Study title expanded, about 7 words
    • Eligibility criteria expanded, about 4 words
    • Study description shortened, about 2 words
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to assess short and long term outcomes after radiofrequency ablation (RFA) of pulmonary malignancies in patients who are not candidates for surgical resection. This study will evaluate the efficacy of RFA for the treatment of lung tumors by assessing its impact on local tumor control, progression free survival, overall survival, dyspnea score and quality of life (QOL).
Trial Details
NCT Number NCT00280189
Lead Sponsor University of Pittsburgh
Collaborators: RITA Medical Systems
Conditions
(from sponsor)		 NSCLC, Pulmonary Metastases
Enrollment 72 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov